4/A//SEC Filing
Smith Jason Drew 4/A
Accession 0001437749-24-003155
CIK 0001668243other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 9:16 PM ET
Size
7.6 KB
Accession
0001437749-24-003155
Insider Transaction Report
Form 4/AAmended
Smith Jason Drew
General Counsel
Transactions
- Sale
Ordinary Shares
2024-02-01$15.78/sh−417$6,580→ 18,824 total - Sale
Ordinary Shares
2024-02-01$15.78/sh−1,248$19,693→ 20,076 total - Sale
Ordinary Shares
2024-02-01$15.78/sh−3,328$52,516→ 23,414 total
Footnotes (2)
- [F1]This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024.
- [F2]This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001821479
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 9:16 PM ET
- Size
- 7.6 KB